Platz KP - Search Results

1

Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters.

Mueller AR, Platz KP, Berg T, Guckelberger O, Neuhaus R, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1997 Nov;29(7):2843-5. doi: 10.1016/s0041-1345(97)00701-x. Transplant Proc. 1997. PMID: 9365585 No abstract available.

2

Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.

Mueller AR, Platz K, Willimski C, Berg T, Steinmüller T, Neumann U, Neuhaus R, Hopf U, Radke C, Neuhaus P. Mueller AR, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1347-9. doi: 10.1016/s0041-1345(00)02504-5. Transplant Proc. 2001. PMID: 11267321 No abstract available.

3

Monitoring of immunosuppression after clinical small bowel transplantation.

Pascher A, Sauer IM, Schulz RJ, Platz K, Theruvath T, Dignass A, Radke C, Neuhaus P, Mueller AR. Pascher A, et al. Transplant Proc. 2002 May;34(3):931-3. doi: 10.1016/s0041-1345(02)02676-3. Transplant Proc. 2002. PMID: 12034245 No abstract available.

4

Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplantation. 1994 Jul 27;58(2):155-70. Transplantation. 1994. PMID: 7518974 Clinical Trial.

5

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Platz KP, et al. Transplantation. 1994 Jul 27;58(2):170-8. Transplantation. 1994. PMID: 7518975 Clinical Trial.

6

Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.

Mueller AR, Platz KP, Christe W, Bechstein WO, Blumhardt G, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3131-2. Transplant Proc. 1994. PMID: 7527951 Clinical Trial. No abstract available.

7

Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients.

Platz KP, Mueller AR, Bechstein WO, Blumhardt G, Neuhaus P. Platz KP, et al. Transplant Proc. 1994 Dec;26(6):3133-4. Transplant Proc. 1994. PMID: 7527952 Clinical Trial. No abstract available.

8

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.

Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3637-9. Transplant Proc. 1994. PMID: 7527984 No abstract available.

9

Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, et al. Neuhaus P, et al. Among authors: platz kp. Transplantation. 1995 Jan 15;59(1):31-40. doi: 10.1097/00007890-199501150-00007. Transplantation. 1995. PMID: 7530868 Clinical Trial.

10

OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.

Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Platz KP, et al. Transplant Proc. 1995 Feb;27(1):1111-3. Transplant Proc. 1995. PMID: 7533357 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters